Law Firms Court Lead Plaintiff for New Boston Scientific Securities Class Action

Overview

• Robbins Geller and the Law Offices of Howard G. Smith are inviting Boston Scientific shareholders with losses to seek lead-plaintiff status in a newly filed federal class action.
• Filed in the District of Massachusetts as Troike v. Boston Scientific Corporation, No. 26-cv-40075, the suit covers trades from July 23, 2025 to February 3, 2026.
• The complaint claims the company misled investors about its revenue outlook and growth, including confidence in its U.S. electrophysiology business, which treats heart rhythm problems.
• The filing ties the alleged misstatements to the company’s February results that came in below EPS guidance and a stock drop of more than 17%, according to the complaint.
• Under the Private Securities Litigation Reform Act, the investor appointed as lead plaintiff will help choose counsel and guide the case, and the allegations have not been proven.